These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 36524461)
1. FAM3D inhibits gluconeogenesis in high glucose environment via DUSP1/ZFP36/SIK1 axis. Huang B; Luo YL; Huang JL; Li GZ; Qiu SY; Huang CC Kaohsiung J Med Sci; 2023 Mar; 39(3):254-265. PubMed ID: 36524461 [TBL] [Abstract][Full Text] [Related]
2. SIK1 Regulates CRTC2-Mediated Gluconeogenesis Signaling Pathway in Human and Mouse Liver Cells. Wang C; Song D; Fu J; Wen X Front Endocrinol (Lausanne); 2020; 11():580. PubMed ID: 33013689 [TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated expression of SIK1 improves hepatic glucose and lipid metabolism in type 2 diabetes mellitus rats. Song D; Yin L; Wang C; Wen X PLoS One; 2019; 14(6):e0210930. PubMed ID: 31233505 [TBL] [Abstract][Full Text] [Related]
4. Negative Feed-forward Control of Tumor Necrosis Factor (TNF) by Tristetraprolin (ZFP36) Is Limited by the Mitogen-activated Protein Kinase Phosphatase, Dual-specificity Phosphatase 1 (DUSP1): IMPLICATIONS FOR REGULATION BY GLUCOCORTICOIDS. Shah S; Mostafa MM; McWhae A; Traves SL; Newton R J Biol Chem; 2016 Jan; 291(1):110-25. PubMed ID: 26546680 [TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-mediated deletion of adipocyte genes associated with NAFLD alters adipocyte lipid handling and reduces steatosis in hepatocytes in vitro. Lopez-Yus M; Frendo-Cumbo S; Del Moral-Bergos R; Garcia-Sobreviela MP; Bernal-Monterde V; Rydén M; Lorente-Cebrian S; Arbones-Mainar JM Am J Physiol Cell Physiol; 2023 Nov; 325(5):C1178-C1189. PubMed ID: 37721003 [TBL] [Abstract][Full Text] [Related]
6. Activation of SIK1 by phanginin A inhibits hepatic gluconeogenesis by increasing PDE4 activity and suppressing the cAMP signaling pathway. Liu S; Huang S; Wu X; Feng Y; Shen Y; Zhao QS; Leng Y Mol Metab; 2020 Nov; 41():101045. PubMed ID: 32599076 [TBL] [Abstract][Full Text] [Related]
7. Activation of the MKK3-p38-MK2-ZFP36 Axis by Coronavirus Infection Restricts the Upregulation of AU-Rich Element-Containing Transcripts in Proinflammatory Responses. Li S; Liu S; Chen RA; Huang M; Fung TS; Liu DX J Virol; 2022 Mar; 96(5):e0208621. PubMed ID: 34985993 [TBL] [Abstract][Full Text] [Related]
8. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes. Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094 [TBL] [Abstract][Full Text] [Related]
9. Zhenqing recipe attenuates non-alcoholic fatty liver disease by regulating the SIK1/CRTC2 signaling in experimental diabetic rats. Song D; Yin L; Wang C; Wen X BMC Complement Med Ther; 2020 Jan; 20(1):27. PubMed ID: 32020874 [TBL] [Abstract][Full Text] [Related]
10. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053 [TBL] [Abstract][Full Text] [Related]
11. Effect of oxymatrine on liver gluconeogenesis is associated with the regulation of PEPCK and G6Pase expression and AKT phosphorylation. Zhu YX; Hu HQ; Zuo ML; Mao L; Song GL; Li TM; Dong LC; Yang ZB; Ali Sheikh MS Biomed Rep; 2021 Jul; 15(1):56. PubMed ID: 34007449 [TBL] [Abstract][Full Text] [Related]
12. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity. Nixon M; Stewart-Fitzgibbon R; Fu J; Akhmedov D; Rajendran K; Mendoza-Rodriguez MG; Rivera-Molina YA; Gibson M; Berglund ED; Justice NJ; Berdeaux R Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205 [TBL] [Abstract][Full Text] [Related]
13. Dual specificity MAPK phosphatase 3 activates PEPCK gene transcription and increases gluconeogenesis in rat hepatoma cells. Xu H; Yang Q; Shen M; Huang X; Dembski M; Gimeno R; Tartaglia LA; Kapeller R; Wu Z J Biol Chem; 2005 Oct; 280(43):36013-8. PubMed ID: 16126724 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase. Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967 [No Abstract] [Full Text] [Related]
16. Role of salt inducible kinase 1 in high glucose-induced lipid accumulation in HepG2 cells and metformin intervention. Zhang Y; Takemori H; Wang C; Fu J; Xu M; Xiong L; Li N; Wen X Life Sci; 2017 Mar; 173():107-115. PubMed ID: 28174122 [TBL] [Abstract][Full Text] [Related]
17. FAM3D inhibits glucagon secretion via MKP1-dependent suppression of ERK1/2 signaling. Cao T; Yang D; Zhang X; Wang Y; Qiao Z; Gao L; Liang Y; Yu B; Zhang P Cell Biol Toxicol; 2017 Oct; 33(5):457-466. PubMed ID: 28247283 [TBL] [Abstract][Full Text] [Related]
18. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model. Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286 [TBL] [Abstract][Full Text] [Related]
19. Suppression of gluconeogenic gene transcription by SIK1-induced ubiquitination and degradation of CRTC1. Gao WW; Tang HV; Cheng Y; Chan CP; Chan CP; Jin DY Biochim Biophys Acta Gene Regul Mech; 2018 Mar; 1861(3):211-223. PubMed ID: 29408765 [TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rk3 ameliorates high-fat-diet/streptozocin induced type 2 diabetes mellitus in mice via the AMPK/Akt signaling pathway. Liu Y; Deng J; Fan D Food Funct; 2019 May; 10(5):2538-2551. PubMed ID: 30993294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]